ProPhase Labs, Inc. (PRPH )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol PRPH
- Company ProPhase Labs, Inc.
- Price $0.09
- Changes Percentage -35.71
- Change -0.05
- Day Low $0.09
- Day High $0.13
- Year High $6.7
- Year Low $0.12
- Market Cap $663,181
- Price Avg 50 EMA (D) $0.2
- Price Avg 200 EMA (D) $2.64
- Exchange NASDAQ
- Volume 17,139
- Average Volume 1,148,834
- Open $0.12
- Previous Close $0.14
- EPS -19.8
- PE -0.01
- Earnings Announcement 2026-03-30 12:30:00
- Shares Outstanding $4,737,007
Company brief: PROPHASE LABS, INC. (PRPH )
- Healthcare
- Drug Manufacturers - Specialty & Generic
- Mr. Ted William Karkus
- https://www.prophaselabs.com
- US
- N/A
- 04-04-1994
- US74345W1080
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; SARS-CoV-2 (COVID-19) and COVID-19 viral mutation polymerase chain reaction tests through saliva and nasal swab methods; and other respiratory pathogen panel molecular testing services, as well as personal genomics products and services. It serves national chain drug, internet-based, and various regional retailers. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.